Home / Stocks / AMLX

AMLX insider trading

Amylyx Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$189k
Buys · last 90 days
0 · $0
Most recent buy
2026-05-26

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-26Firestone Karen
Director
Bought3,800$13.51$51k
2026-01-20Cohen Joshua B
Co-Chief Executive Officer
Sold136,193$13.59$1.9M
2026-01-20Klee Justin B.
Co-Chief Executive Officer
Sold136,193$13.58$1.8M
2025-12-23Firestone Karen
Director
Bought8,100$12.45$101k
2025-03-24Zeiher Bernhardt G
Director
Bought10,000$3.70$37k

Most active insider buyers

InsiderRoleBuysTotal bought
Firestone KarenDirector2$152k
Zeiher Bernhardt GDirector1$37k

See AMLX on the chart

Every insider buy and sell for AMLX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.